Clinical Trial Update: Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement

View source ↗

Summary

Recruiting trial evaluating upfront targeted axillary dissection (TAD) for luminal breast cancer with limited axillary involvement, aiming to reduce extensive a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: European Institute of Oncology | Conditions: ALND, Sentinel Lymph Node Biopsy (SLNB) | Status: RECRUITING